{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T04:18:55Z","timestamp":1769746735818,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,26]]},"DOI":"10.7759\/cureus.34222","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T12:18:13Z","timestamp":1674735493000},"source":"Crossref","is-referenced-by-count":4,"title":["Important Clues for the Diagnosis of Anti-LGI1-Antibody Autoimmune Encephalitis: A Case Report"],"prefix":"10.7759","author":[{"given":"Mohammad","family":"Abu-Abaa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sindhu","family":"Chadalawada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Jumaah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malik","family":"Abubakar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Landau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2017.11.002","article-title":"LGI1 antibody encephalitis - detailed clinical, laboratory and radiological description of 13 cases in China","volume":"81","author":"Wang D","year":"2018","unstructured":"Wang D, Hao Q, He L, He L, Wang Q. LGI1 antibody encephalitis - detailed clinical, laboratory and radiological description of 13 cases in China. Compr Psychiatry. 2018, 81:18-21. 10.1016\/j.comppsych.2017.11.002","journal-title":"Compr Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-018-1099-z","article-title":"Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study","volume":"18","author":"Li W","year":"2018","unstructured":"Li W, Wu S, Meng Q, et al.. Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study. BMC Neurol. 2018, 18:96. 10.1186\/s12883-018-1099-z","journal-title":"BMC Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1212\/01.CON.0000413664.42798.aa","article-title":"Paraneoplastic disorders of the CNS and autoimmune synaptic encephalitis","volume":"18","author":"Rosenfeld MR","year":"2012","unstructured":"Rosenfeld MR, Dalmau JO. Paraneoplastic disorders of the CNS and autoimmune synaptic encephalitis. Continuum (Minneap Minn). 2012, 18:366-83. 10.1212\/01.CON.0000413664.42798.aa","journal-title":"Continuum (Minneap Minn)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2013.10.005","article-title":"VGKC-complex\/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy","volume":"265","author":"Shin YW","year":"2013","unstructured":"Shin YW, Lee ST, Shin JW, et al.. VGKC-complex\/LGI1-antibody encephalitis: clinical manifestations and response to immunotherapy. J Neuroimmunol. 2013, 265:75-81. 10.1016\/j.jneuroim.2013.10.005","journal-title":"J Neuroimmunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S136723","article-title":"Clinical features of limbic encephalitis with LGI1 antibody","volume":"13","author":"Wang M","year":"2017","unstructured":"Wang M, Cao X, Liu Q, Ma W, Guo X, Liu X. Clinical features of limbic encephalitis with LGI1 antibody. Neuropsychiatr Dis Treat. 2017, 13:1589-96. 10.2147\/NDT.S136723","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70137-X","article-title":"Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series","volume":"9","author":"Lai M","year":"2010","unstructured":"Lai M, Huijbers MG, Lancaster E, et al.. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol. 2010, 9:776-85. 10.1016\/S1474-4422(10)70137-X","journal-title":"Lancet Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2017.05.017","article-title":"LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures","volume":"50","author":"Aurangzeb S","year":"2017","unstructured":"Aurangzeb S, Symmonds M, Knight RK, Kennett R, Wehner T, Irani SR. LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures. Seizure. 2017, 50:14-7. 10.1016\/j.seizure.2017.05.017","journal-title":"Seizure"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-014-7408-6","article-title":"Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity","volume":"261","author":"Malter MP","year":"2014","unstructured":"Malter MP, Frisch C, Schoene-Bake JC, et al.. Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity. J Neurol. 2014, 261:1695-705. 10.1007\/s00415-014-7408-6","journal-title":"J Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22307","article-title":"Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis","volume":"69","author":"Irani SR","year":"2011","unstructured":"Irani SR, Michell AW, Lang B, et al.. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol. 2011, 69:892-900. 10.1002\/ana.22307","journal-title":"Ann Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.07.018","article-title":"From VGKC to LGI1 and Caspr2 encephalitis: the evolution of a disease entity over time","volume":"15","author":"van Sonderen A","year":"2016","unstructured":"van Sonderen A, Schreurs MW, Wirtz PW, Sillevis Smitt PA, Titulaer MJ. From VGKC to LGI1 and Caspr2 encephalitis: the evolution of a disease entity over time. Autoimmun Rev. 2016, 15:970-4. 10.1016\/j.autrev.2016.07.018","journal-title":"Autoimmun Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2010.02756.x","article-title":"Human limbic encephalitis serum enhances hippocampal mossy fiber-CA3 pyramidal cell synaptic transmission","volume":"52","author":"Lalic T","year":"2011","unstructured":"Lalic T, Pettingill P, Vincent A, Capogna M. Human limbic encephalitis serum enhances hippocampal mossy fiber-CA3 pyramidal cell synaptic transmission. Epilepsia. 2011, 52:121-31. 10.1111\/j.1528-1167.2010.02756.x","journal-title":"Epilepsia"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.2005.00406.x","article-title":"FDG-PET and MRI in potassium channel antibody-associated non-paraneoplastic limbic encephalitis: correlation with clinical course and neuropsychology","volume":"111","author":"Fauser S","year":"2005","unstructured":"Fauser S, Talazko J, Wagner K, Ziyeh S, Jarius S, Vincent A, Schulze-Bonhage A. FDG-PET and MRI in potassium channel antibody-associated non-paraneoplastic limbic encephalitis: correlation with clinical course and neuropsychology. Acta Neurol Scand. 2005, 111:338-43. 10.1111\/j.1600-0404.2005.00406.x","journal-title":"Acta Neurol Scand"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003009","article-title":"Anti-LGI1-associated cognitive impairment: presentation and long-term outcome","volume":"87","author":"Ari\u00f1o H","year":"2016","unstructured":"Ari\u00f1o H, Armangu\u00e9 T, Petit-Pedrol M, et al.. Anti-LGI1-associated cognitive impairment: presentation and long-term outcome. Neurology. 2016, 87:759-65. 10.1212\/WNL.0000000000003009","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000248","article-title":"LGI1 antibody encephalopathy overlapping with sporadic Creutzfeldt-Jakob disease","volume":"3","author":"Kim B","year":"2016","unstructured":"Kim B, Yoo P, Sutherland T, Boyd A, Stehmann C, McLean C, Collins S. LGI1 antibody encephalopathy overlapping with sporadic Creutzfeldt-Jakob disease. Neurol Neuroimmunol Neuroinflamm. 2016, 3:e248. 10.1212\/NXI.0000000000000248","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-015-0410-6","article-title":"Antibody-mediated autoimmune encephalopathies and immunotherapies","volume":"13","author":"Gastaldi M","year":"2016","unstructured":"Gastaldi M, Thouin A, Vincent A. Antibody-mediated autoimmune encephalopathies and immunotherapies. Neurotherapeutics. 2016, 13:147-62. 10.1007\/s13311-015-0410-6","journal-title":"Neurotherapeutics"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/134269-important-clues-for-the-diagnosis-of-anti-lgi1-antibody-autoimmune-encephalitis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:57:42Z","timestamp":1707508662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/134269-important-clues-for-the-diagnosis-of-anti-lgi1-antibody-autoimmune-encephalitis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,26]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.34222","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,26]]}}}